1. Home
  2. ATRC vs ICHR Comparison

ATRC vs ICHR Comparison

Compare ATRC & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • ICHR
  • Stock Information
  • Founded
  • ATRC 2000
  • ICHR 1999
  • Country
  • ATRC United States
  • ICHR United States
  • Employees
  • ATRC N/A
  • ICHR N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • ICHR Semiconductors
  • Sector
  • ATRC Health Care
  • ICHR Technology
  • Exchange
  • ATRC Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • ATRC 1.1B
  • ICHR 1.0B
  • IPO Year
  • ATRC 2005
  • ICHR 2016
  • Fundamental
  • Price
  • ATRC $39.84
  • ICHR $28.21
  • Analyst Decision
  • ATRC Strong Buy
  • ICHR Strong Buy
  • Analyst Count
  • ATRC 9
  • ICHR 8
  • Target Price
  • ATRC $43.00
  • ICHR $42.50
  • AVG Volume (30 Days)
  • ATRC 618.4K
  • ICHR 242.3K
  • Earning Date
  • ATRC 02-12-2025
  • ICHR 02-04-2025
  • Dividend Yield
  • ATRC N/A
  • ICHR N/A
  • EPS Growth
  • ATRC N/A
  • ICHR N/A
  • EPS
  • ATRC N/A
  • ICHR N/A
  • Revenue
  • ATRC $447,573,000.00
  • ICHR $819,230,000.00
  • Revenue This Year
  • ATRC $18.02
  • ICHR $6.47
  • Revenue Next Year
  • ATRC $12.93
  • ICHR $16.72
  • P/E Ratio
  • ATRC N/A
  • ICHR N/A
  • Revenue Growth
  • ATRC 17.56
  • ICHR N/A
  • 52 Week Low
  • ATRC $18.94
  • ICHR $25.95
  • 52 Week High
  • ATRC $43.11
  • ICHR $46.43
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 61.66
  • ICHR 41.57
  • Support Level
  • ATRC $39.71
  • ICHR $26.19
  • Resistance Level
  • ATRC $43.11
  • ICHR $28.63
  • Average True Range (ATR)
  • ATRC 1.86
  • ICHR 1.44
  • MACD
  • ATRC 0.15
  • ICHR -0.21
  • Stochastic Oscillator
  • ATRC 63.10
  • ICHR 31.04

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, the United Kingdom, Singapore, Malaysia, Korea, and Mexico, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: